Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma
Titel:
Discontinuing VEGF-targeted Therapy for Progression Versus Toxicity Affects Outcomes of Second-line Therapies in Metastatic Renal Cell Carcinoma
Auteur:
De Velasco, Guillermo Xie, Wanling Donskov, Frede Albiges, Laurence Beuselinck, Benoit Srinivas, Sandy Agarwal, Neeraj Lee, Jae Lyun Brugarolas, James Wood, Lori A. Rha, Sun-young Kollmannsberger, Christian North, Scott Kanesvaran, Ravindran Rini, Brian I. Broom, Reuben Yamamoto, Haru Kaymakcalan, Marina D. Heng, Daniel Y.C. Choueiri, Toni K.